THC Farmaceuticals, Inc. Cashflow Statement

Ask AI

Financial Statements

In USD, except per-share amounts

	FY2014 12 months to Sep 30, 2014	FY2013 12 months to Sep 30, 2013	FY2012 12 months to Sep 30, 2012	FY2011 12 months to Sep 30, 2011
Cash Flows From Operating Activities
Net Loss
Adjustments to reconcile net loss to net cash from operating activities:
Forgiveness of Note Receivable
Interest Accrual on Notes Receivable
Depreciation
(Increase) Decrease in restricted cash
Impairment of Intangible Assets
Loss on sale of equipment
(Increase)/Decrease in accounts receivable
Increase/(Decrease) in accounts payable
Accrued interest on related party loan
Net Cash from Operating Activities

Notes Receivable
Proceeds from sale of equipment
Cash Flows from Financing Activities
Proceeds from issuance of common stock
Principal payments on Notes Payable
Payments on Related Party Loan
Proceeds from notes payable to related parties
Net Cash from Financing Activities

Net Increase/(Decrease) in Cash
Cash Balance Beginning of Period
Cash Balance End of Period
Net Increase/(Decrease) in Cash
Beginning Cash Balance
Ending Cash Balance
Supplemental Disclosure of Cash Flow Information
Cash paid during the period for interest
Cash paid during the period for taxes

Equipment Exchanged for common stock in conjunction with reverse merger
Total Non-Cash Transactions
Assets acquired in exchange for related party debt

Comments